When the US benchmarks drug prices against other countries, the whole world feels it. In this episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Brittany La Couture of Applied Policy, a health policy attorney with eight years at the Centers for Medicare & Medicaid Services, to unpack the US “most favored nation” approach to drug pricing and the three CMMI models behind it: GENEROUS, GLOBE and GUARD.
They discuss why providers and patients may carry the cost, why Brittany sees the models as a tax on manufacturers rather than a price cut, and whether launch delays in Europe point to a more fragmented global market.
Stay connected by subscribing on your favorite podcast platform or listening directly on our website: MAP Podcasts — and if you enjoyed the episode, don't forget to rate it and the podcast!
MAP is the first and only bi-weekly market access podcast provided by MArS — and the global #1 podcast in the field of health economics. For more information about MArS Market Access and Pricing Strategy, visit: https://marketaccess4-0.com/
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Stefan Walzer. Innehållet i podden är skapat av Dr. Stefan Walzer och inte av,
eller tillsammans med, Poddtoppen.
